Genetic Studies of SMN2 in Russian Patients with Spinal Muscular Atrophy
Author Information
Author(s): Zheleznyakova Galina Yu, Kiselev Anton V, Vakharlovsky Viktor G, Rask-Andersen Mathias, Chavan Rohit, Egorova Anna A, Schiöth Helgi B, Baranov Vladislav S
Primary Institution: Ott's Institute of Obstetrics and Gynecology RAMS
Hypothesis
The SMN2 gene copy number can be used as a prognostic tool to differentiate between SMA type II and type III.
Conclusion
Quantifying the SMN2 gene copy number can help distinguish between SMA type II and type III diagnoses.
Supporting Evidence
- Most SMA type II patients have three copies of the SMN2 gene.
- A significant correlation was found between having four copies of SMN2 and a milder SMA phenotype.
- Two families of asymptomatic carriers of SMN1 deletion were identified.
Takeaway
This study looks at a gene that affects a disease called spinal muscular atrophy, and it found that counting copies of this gene can help doctors tell how serious the disease is.
Methodology
Real-time PCR was used to quantify SMN2 gene copy number in SMA patients.
Limitations
The study may not account for all genetic factors influencing SMA severity.
Participant Demographics
Russian patients with spinal muscular atrophy type II and III.
Statistical Information
P-Value
0.0233
Statistical Significance
p = 0.0233
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website